Ziyi Hu
State Key Laboratory Of Innovative Immunotherapy
Shanghai, China
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Noncovalent Interaction of 1-Ethyl-4-(Methoxycarbonyl)Pyridinium Iodide with Conjugated Polymer-Wrapped Single-Walled Carbon Nanotubes: Dependence of Molecular Arrangement on the Nanotube Characteristics.
Journal: The journal of physical chemistry. B
Published: May 04, 2026
Artemisinin sensitizes triple negative breast cancer to immune checkpoint therapy through suppressing KEAP1-mediated PD-L1 degradation.
Journal: Biochemical pharmacology
Published: October 10, 2025
A complex network perspective on spatiotemporal evolution of extreme precipitation over the middle and lower reaches of the Yangtze river.
Journal: Scientific reports
Published: January 07, 2025
Promoting macrophage phagocytosis of cancer cells for effective cancer immunotherapy.
Journal: Biochemical pharmacology
Published: October 02, 2024
MHC1/LILRB1 axis as an innate immune checkpoint for cancer therapy.
Journal: Frontiers in immunology
Published: April 21, 2024
Caffeine intake and anxiety: a meta-analysis.
Journal: Frontiers in psychology
Published: July 31, 2023
A glycosylation-related gene signature predicts prognosis, immune microenvironment infiltration, and drug sensitivity in glioma.
Journal: Frontiers in pharmacology
Published: July 15, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026